| Wellchange Holdings Company Limited Announces 1-for-10 Reverse Stock Split Effective November 9, 2026 |
Globe Newswire |
11/05 |
08:00 |
| Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/05 |
08:00 |
| EVgo Opens First Supercharger Site as Part of Network Expansion |
Globe Newswire |
11/05 |
08:00 |
| Novastra Therapeutics Establishes Scientific Advisory Board and Appoints Senior Advisors and Head of Clinical Development |
Globe Newswire |
11/05 |
08:00 |
| Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System |
Globe Newswire |
11/05 |
08:00 |
| Freshpet, Inc. to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/05 |
08:00 |
| VeonGen Announces FDA Alignment on Pivotal Phase 3 Development and Clinical Progress of VG801 for Stargardt Disease |
Globe Newswire |
11/05 |
08:00 |
| Aemetis Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
08:00 |
| NETSOL Technologies to report fiscal first quarter 2027 results on November 12 |
Globe Newswire |
11/05 |
08:00 |
| Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November |
Globe Newswire |
11/05 |
08:00 |
| Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI), Westwood Enhanced Income Opportunity ETF (YLDW) and Westwood Enhanced Power & Infrastructure ETF (PWRX) |
Globe Newswire |
11/05 |
08:00 |
| PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product |
Globe Newswire |
11/05 |
08:00 |
| Verrica Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 |
Globe Newswire |
11/05 |
08:00 |
| LaunchDarkly Introduces Release Autopilot, Automating Release Safeguards for AI-Written Code |
Globe Newswire |
11/05 |
08:00 |
| FERC Authorizes MARA’s Acquisition of Long Ridge Energy & Power, Finds Transaction Consistent with the Public Interest |
Globe Newswire |
11/05 |
08:00 |
| Dune Completes SOC 2 Type II as Tokenized Assets Doubled to $32.6B |
Globe Newswire |
11/05 |
08:00 |
| Globalstar Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
08:00 |
| Portillo’s Inc. Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
08:00 |
| Forward Therapeutics Announces U.S. FDA IND Clearance to Initiate Phase 2 Study of FT2109 in Psoriatic Arthritis |
Globe Newswire |
11/05 |
08:00 |
| OFA Group Announces 10-for-1 Consolidation of Class A Ordinary Shares |
Globe Newswire |
11/05 |
08:00 |
| Zscaler to Host First Quarter Fiscal Year 2027 Earnings Conference Call |
Globe Newswire |
11/05 |
08:00 |
| Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
11/05 |
08:00 |
| Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis |
Globe Newswire |
11/05 |
08:00 |
| Tejon Ranch Co. Announces Third Quarter 2026 Financial Results |
Globe Newswire |
11/05 |
08:00 |
| AIR Submits Premarket Tobacco Product Application for Crown Switch Rechargeable Pod Vape Platform |
Globe Newswire |
11/05 |
08:00 |
